Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
about
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitorsABL1 fusion genes in hematological malignancies: a review.NUP214 fusion genes in acute leukemia (Review).Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34).Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia.In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL.Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia.Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic LeukemiaNucleoporin Gene Fusions and Hematopoietic Malignancies
P2860
Q35171267-49577924-4D7D-49BA-BD01-66E103B77B61Q36174146-CC535145-9B6B-418C-9FFF-1BDADCAF8BBCQ37216300-D0581FA5-9800-4EE8-A222-410529AAAF6DQ37857340-B3332445-DA91-4A2A-AA7E-49B35E134F2AQ38239669-A00C0630-0E97-4EE7-9078-64B73148F59FQ38999126-807C7423-DA1D-4BC0-80E8-B25C0C96ADCDQ39041475-B5EDBDA1-76F0-48E7-9E52-FB9C54EC4CF9Q39122858-96B5B026-01DA-4444-90FD-2E27FFE457EBQ42574039-D1F3DC5B-5B9F-4349-88D1-5A13FE92674AQ44712646-0FCFD03C-5EFF-4BBB-96E7-2EBD9C8FD8D7Q46416550-E074BA84-27A0-463D-B76C-825F048C707FQ47094344-63F337D2-EC53-4EA7-BC38-E3B560C1355BQ47155885-A7BD3F8F-3828-4994-8519-351D4091BBC3Q54504915-7D6FE384-E165-4D4C-BD6E-86EB2E5C4138Q54605683-5673C4EF-8148-4C2C-94CC-82966CB5D265Q58785945-8614CEFB-FB67-4A37-B41C-758C6624C8AEQ59072645-4322D841-A228-4BF5-9C6D-10BE04292C46
P2860
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Rapid complete cytogenetic rem ...... acute lymphoblastic leukemia.
@en
Rapid complete cytogenetic rem ...... acute lymphoblastic leukemia.
@nl
type
label
Rapid complete cytogenetic rem ...... acute lymphoblastic leukemia.
@en
Rapid complete cytogenetic rem ...... acute lymphoblastic leukemia.
@nl
prefLabel
Rapid complete cytogenetic rem ...... acute lymphoblastic leukemia.
@en
Rapid complete cytogenetic rem ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Rapid complete cytogenetic rem ...... acute lymphoblastic leukemia.
@en
P2093
H B Beverloo
J J Cornelissen
J W J van Esser
M M Wattel
P J M Valk
S C P A M van der Poel-van de Luytgaarde
P2860
P2888
P304
P356
10.1038/LEU.2008.318
P577
2008-11-06T00:00:00Z